Published March 2007 | Version v1
Journal article

A comparision between adrenomedullin, endothelin and angiotensin II in patients with congestive heart failure

  • 1. Department of Labouratory, Zhanjiang Second Hospital, Zhanjian (China)
  • 2. Department of Nuclear Medicine, Guangdong Medical College of Appertain Hospital, Guangdong (China)

Description

Objective: To observe the changes of plasma adrenomedu (AM), endothelin (ET) and angioteusin II (Ang II) in patients with congestive heart failure (CHF). Methods: Plasma AM, ET and Ang II levels were determined by radioimmuncassay in 95 patients with CHF and 50 healthy control subjects. In 95 patients with CHF, the left ventricular ejection fraction (LVEF) of 56 patients was measured by echocardiography. Results: The plasma AM levels were significantly higher in patients with CHF than that in control subjects. The increase of plasma AM, ET and Ang II was parallel with the severity of CHF. There was a significant co,elation between plasma levels of AM and ET (r=0.7218, P<0.01) and Ang II (r=0.6566, P<0.001). LVEF inversely correlated(r=-0.6258, P<0.001) with plasma AM levels and significantly positive correlated between the plains AM levels and the cardiothoracic ration(r=0.6037, P<0.05) in patients with CHF. Conclusions These results suggest that AM might play a certain role in the pathophysiology of CHF. The elevated plasma ET and Ang II may be responsible for the rise of plasma AM levels in patients with CHF. (authors)

Additional details

Publishing Information

Journal Title
International Journal of Radiation Medicine and Nuclear Medicine
Journal Volume
31
Journal Issue
2
Journal Page Range
p. 96-97, 101
ISSN
1673-4114

INIS

Country of Publication
China
Country of Input or Organization
China
INIS RN
40041062
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ANGIOTENSIN; CONTROL; HEART FAILURE; PATIENTS; PLASMA; RISE
Descriptors DEC
CARDIOVASCULAR AGENTS; DRUGS; GLOBULINS; MODIFIED IN-SITU PROCESSES; ORGANIC COMPOUNDS; PROTEINS; SYMPTOMS; VASOCONSTRICTORS

Optional Information

Notes
3 tabs., 5 refs.